Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan Burger

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Diagnostics (Basel, Switzerland)|November 11, 2022
Exploring Urinary Extracellular Vesicles and Immune Mediators as Biomarkers of Kidney Injury in COVID-19 Hospitalized PatientsThalia Medeiros, Lilian Santos Alves, Mauro Jorge Cabral-Castro, et al.
Journal of Ovarian Research|November 25, 2025
Circulating plasma gelsolin and MRI-based radiomics as biomarkers of platinum resistance in epithelial ovarian cancer: building a multiparameteric prediction algorithmEmma Gerber, Rahul Singh, Cheuk Nam Hwang, et al.
Diabetologia|November 4, 2020
Correction to: Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetesKatie M Sullivan, James Scholey, Rahim Moineddin, et al.
Diabetologia|October 10, 2020
Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetesKatie M Sullivan, James Scholey, Rahim Moineddin, et al.
Journal of Extracellular Vesicles|February 14, 2018
Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36Mercedes N Munkonda, Shareef Akbari, Chloe Landry, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2019
Prostaglandin E2 receptor EP1 (PGE2/EP1) deletion promotes glomerular podocyte and endothelial cell injury in hypertensive TTRhRen miceRania Nasrallah, Joseph Zimpelmann, Susan J Robertson, et al.
Cancers|May 13, 2023
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian CancerMeshach Asare-Werehene, Robert A Hunter, Emma Gerber, et al.
Molecular Therapy. Advances|June 3, 2026
Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophyKathy L Poulin, Charlotte A René, Ian C Smith, et al.
Journal of Extracellular Vesicles|December 6, 2023
A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapyFrederic St-Denis-Bissonnette, Sarah E Cummings, Shirley Qiu, et al.
Molecular Therapy. Oncology|July 1, 2026
Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicityFrederic St-Denis-Bissonnette, Karan Mediratta, Nicholas Ho, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Diagnostics (Basel, Switzerland)|November 11, 2022
Exploring Urinary Extracellular Vesicles and Immune Mediators as Biomarkers of Kidney Injury in COVID-19 Hospitalized PatientsThalia Medeiros, Lilian Santos Alves, Mauro Jorge Cabral-Castro, et al.
Journal of Ovarian Research|November 25, 2025
Circulating plasma gelsolin and MRI-based radiomics as biomarkers of platinum resistance in epithelial ovarian cancer: building a multiparameteric prediction algorithmEmma Gerber, Rahul Singh, Cheuk Nam Hwang, et al.
Diabetologia|November 4, 2020
Correction to: Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetesKatie M Sullivan, James Scholey, Rahim Moineddin, et al.
Diabetologia|October 10, 2020
Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetesKatie M Sullivan, James Scholey, Rahim Moineddin, et al.
Journal of Extracellular Vesicles|February 14, 2018
Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36Mercedes N Munkonda, Shareef Akbari, Chloe Landry, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2019
Prostaglandin E2 receptor EP1 (PGE2/EP1) deletion promotes glomerular podocyte and endothelial cell injury in hypertensive TTRhRen miceRania Nasrallah, Joseph Zimpelmann, Susan J Robertson, et al.
Cancers|May 13, 2023
The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian CancerMeshach Asare-Werehene, Robert A Hunter, Emma Gerber, et al.
Molecular Therapy. Advances|June 3, 2026
Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophyKathy L Poulin, Charlotte A René, Ian C Smith, et al.
Journal of Extracellular Vesicles|December 6, 2023
A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapyFrederic St-Denis-Bissonnette, Sarah E Cummings, Shirley Qiu, et al.
Molecular Therapy. Oncology|July 1, 2026
Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicityFrederic St-Denis-Bissonnette, Karan Mediratta, Nicholas Ho, et al.
Pageof 16